GlassScriptPhysician profile
Jayme Lynn Baumcratz
NPI 1518612688
$1,550.32
in general payments reported to CMS, 2019-2025
19 companies · $566 in 2025
The $566 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $116 · 2023: $488 · 2024: $380 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.44 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $333.91 | 2023-2025 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $215.04 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $208.01 | 2023-2025 | |
| Amgen INC. | $199.47 | 2022-2025 | Evenity, Prolia, Prolia |
| Exact Sciences Corporation | $153.83 | 2024-2025 | Cologuard Collection Kit |
| Organon LLC | $69.56 | 2023-2024 | Nexplanon |
| Myriad Women'S Health, INC. | $54.87 | 2023 | Myrisk |
| Supernus Pharmaceuticals, INC. | $47.58 | 2025 | Qelbree |
| Abbvie INC. | $47.03 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $38.50 | 2025 | Myfembree |
| Daiichi Sankyo INC. | $33.40 | 2022 | |
| Radius Health, INC. | $31.69 | 2023-2024 | Tymlos |
| Convatec INC. | $21.98 | 2023 | |
| Kedrion Biopharma, INC. | $18.82 | 2023 | Gammaked, Kedrab, Koate |
| Mayne Pharma Commercial LLC | $18.70 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $14.91 | 2023 | Slynd |
| Shield Therapeutics INC | $14.78 | 2025 | |
| Coopersurgical, INC. | $14.15 | 2022 | |
| Cosette Pharmaceuticals INC. | $14.09 | 2024 | Vyleesi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayme Baumcratz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.